Metabolic fingerprints of proliferative diabetic retinopathy: an 1H-NMR-based metabonomic approach using vitreous humor
- PMID: 20375324
- DOI: 10.1167/iovs.10-5348
Metabolic fingerprints of proliferative diabetic retinopathy: an 1H-NMR-based metabonomic approach using vitreous humor
Abstract
Purpose: To explore the metabolic profile of vitreous fluid of patients with proliferative diabetic retinopathy (PDR) using 1H-NMR-based metabonomic analysis.
Methods: 1H-NMR spectra were acquired from vitreous samples obtained during vitrectomy from 22 patients with type 1 diabetes with PDR and from 22 nondiabetic patients with macular hole (control group). Data analysis included a principal component analysis and partial least squares discriminant analysis (PLS-DA). In addition, 1H-(1)H and 1H-(13)C HMQC correlation spectra were acquired for the identification of metabolites. Furthermore, the main metabolites accounting for the differences in metabolic profile were assessed by current biochemical methods.
Results: Lactate was the most abundant metabolite, and it was present at higher levels in samples from PDR patients than from nondiabetic patients (P=0.02). Glucose was significantly higher in samples from PDR patients than nondiabetic patients (P=0.03). After removing the lactate peak at 1.35 ppm and with the use of PLS-DA, a model was obtained that was able to correctly classify 19 of 22 patients with PDR and 18 of 22 controls, resulting in a sensitivity of 86% and a specificity of 81%. The main metabolites involved in this specific pattern recognition were galactitol and ascorbic acid (AA); levels of both were significantly lower in PDR patients.
Conclusions: 1H-NMR-based metabonomic analysis of vitreous fluid permits the obtainment of a metabolic signature of PDR. Apart from the higher abundance of lactate and glucose, significant deficits of galactitol and AA are the main metabolic fingerprints of vitreous fluid from PDR patients.
Similar articles
-
Recent Advances and Perspectives in Relation to the Metabolomics-Based Study of Diabetic Retinopathy.Metabolites. 2023 Sep 12;13(9):1007. doi: 10.3390/metabo13091007. Metabolites. 2023. PMID: 37755287 Free PMC article. Review.
-
Atrial natriuretic peptide in the vitreous humor and epiretinal membranes of patients with proliferative diabetic retinopathy.Mol Vis. 2004 Jul 15;10:450-7. Mol Vis. 2004. PMID: 15273657
-
Immunoreactive endothelin-1 in the vitreous humor and epiretinal membranes of patients with proliferative diabetic retinopathy.Retina. 2007 Feb;27(2):222-35. doi: 10.1097/01.iae.0000231376.76601.40. Retina. 2007. PMID: 17290206
-
Vitreous levels of angiopoietin 2 and vascular endothelial growth factor in patients with proliferative diabetic retinopathy.Am J Ophthalmol. 2005 Mar;139(3):476-81. doi: 10.1016/j.ajo.2004.10.004. Am J Ophthalmol. 2005. PMID: 15767056
-
Metabolomics of Diabetic Retinopathy.Curr Diab Rep. 2017 Sep 23;17(11):102. doi: 10.1007/s11892-017-0939-3. Curr Diab Rep. 2017. PMID: 28940103 Review.
Cited by
-
Metabolomics studies in common multifactorial eye disorders: a review of biomarker discovery for age-related macular degeneration, glaucoma, diabetic retinopathy and myopia.Front Mol Biosci. 2024 Aug 13;11:1403844. doi: 10.3389/fmolb.2024.1403844. eCollection 2024. Front Mol Biosci. 2024. PMID: 39193222 Free PMC article. Review.
-
Usefulness of the vitreous fluid analysis in the translational research of diabetic retinopathy.Mediators Inflamm. 2012;2012:872978. doi: 10.1155/2012/872978. Epub 2012 Sep 17. Mediators Inflamm. 2012. PMID: 23028204 Free PMC article. Review.
-
New insight of metabolomics in ocular diseases in the context of 3P medicine.EPMA J. 2023 Feb 17;14(1):53-71. doi: 10.1007/s13167-023-00313-9. eCollection 2023 Mar. EPMA J. 2023. PMID: 36866159 Free PMC article. Review.
-
Iron overload in diabetic retinopathy: a cause or a consequence of impaired mechanisms?Exp Diabetes Res. 2010;2010:714108. doi: 10.1155/2010/714108. Epub 2010 Aug 8. Exp Diabetes Res. 2010. PMID: 20827392 Free PMC article. Review.
-
Recent Advances and Perspectives in Relation to the Metabolomics-Based Study of Diabetic Retinopathy.Metabolites. 2023 Sep 12;13(9):1007. doi: 10.3390/metabo13091007. Metabolites. 2023. PMID: 37755287 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical